Context 68 Gallium prostate-specific membrane antigen positron emission tomography (68
Ga-PSMA PET) is an emerging imaging modality for assessment of prostate cancer. Recent …

Context Positron emission tomography (PET) of 68 Ga-labelled prostate-specific membrane
antigen (68 Ga-PSMA) is an emerging imaging modality introduced to assess the burden of …

Context Accurate staging of high-risk localised, advanced, and metastatic prostate cancer is
becoming increasingly more important in guiding local and systemic treatment. Gallium-68 …

Context 68 Gallium prostate-specific membrane antigen (PSMA) ligand 68 Ga-HBED-CC-
PSMA (68 Ga-PSMA) is a promising radiotracer for positron emission tomography …

68Ga-PSMA PET/CT scanning has been shown to be more sensitive than conventional
imaging techniques in patients with prostate cancer. This prospective Australian multicenter …

Background Prostate-specific membrane antigen (PSMA) positron emission tomography
(PET)/computed tomography (CT) has become an increasingly established imaging …

The impact of prostate-specific membrane antigen (PSMA) PET/CT on management of
prostate cancer (PCa) patients with biochemical recurrence (BCR) is well established …

Background Accurate staging is of major importance to determine the optimal treatment
modality for patients with prostate cancer. Positron emission tomography (PET) with prostate …

Context In the past 10 yr, several agents based on prostate-specific membrane antigen
(PSMA) for positron emission tomography imaging have been introduced in clinical practice …

Objectives The primary objective was the evaluation of Gallium 68 (68 Ga)-prostate-specific
membrane antigen (PSMA)-11 positron emission tomography/computed tomography …